Aurelia A. Haller - Concepedia

Concepedia

Author

Aurelia A. Haller

University of California, Irvine

Also Known As

A A Haller, Angel Haller, Anne-Sophie Haller, Aurelia A Haller, Aurelia A. Haller, Aurelia Haller

24

Publications

1.4K

Citations

19

H-Index

33

Concepts

All Affiliations

University of California, Irvine Erasmus MC Takeda (United States)Erasmus University Rotterdam Centers for Disease Control and Prevention

AA

About

Aurelia A. Haller is an author at University of California, Irvine specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	1.1K
2	Natural Sciences	5	5	248
3	Cell Biology	3	3	141
4	Allergy	1	1	89
5	Biomolecular Engineering	1	1	20

Aurelia A. Haller

×

20

Publications

1.4K

Citations

19

H-Index

	Year	Citations
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study Jorge E. Osorio, Iván Darío Vélez, Cynthia A. Thomson, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentGlobal HealthVirology	2014	149
Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design Mia MacPhail, Jeanne H. Schickli, Roderick S. Tang, Journal of General Virology VaccinationHmpv Vaccine DesignRespiratory Virus ImmunityVaccine DevelopmentVaccine Target	2004	126
Recovery of Human Metapneumovirus Genetic Lineages A and B from Cloned cDNA Sander Herfst, Miranda de Graaf, Jeanne H. Schickli, Journal of Virology Hmpv IsolatesViral ReplicationViral EvolutionMinigenome ConstructsMolecular Virology	2004	109
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins Aurelia A. Haller, Georg M. Lauer, Thomas H. King, Vaccine Adaptive Immune SystemT-regulatory CellImmunologyHcv Ns3Core Proteins	2006	105
Effects of Human Metapneumovirus and Respiratory Syncytial Virus Antigen Insertion in Two 3′ Proximal Genome Positions of Bovine/Human Parainfluenza Virus Type 3 on Virus Replication and Immunogenicity Roderick S. Tang, Jeanne H. Schickli, Mia MacPhail, Journal of Virology	2003	96
A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys Roderick S. Tang, Kutubuddin Mahmood, Mia MacPhail, Vaccine VaccinationMolecular VirologyPathogenesisImmunologyViral Pathogenesis	2004	93
Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA Aurelia A. Haller, Bert L. Semler Journal of Virology Poliovirus RnaVirus StructureViral ReplicationNatural SciencesPathogenesis	1992	92
Parainfluenza Virus Type 3 Expressing the Native or Soluble Fusion (F) Protein of Respiratory Syncytial Virus (RSV) Confers Protection from RSV Infection in African Green Monkeys Roderick S. Tang, Mia MacPhail, Jeanne H. Schickli, Journal of Virology Respiratory Virus ImmunityImmunologyViral PathogenesisVirus StructureRespiratory Disease	2004	89
Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial Sarah L. George, Mimi Wong, Tina Dube, The Journal of Infectious Diseases	2015	86
Expression of the Surface Glycoproteins of Human Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a Novel Attenuated Virus Vaccine Vector Aurelia A. Haller, Tessa Miller, Misrach Mitiku, Journal of Virology	2000	79

Page 1